Corning Incorporated vs Liquidia Corporation Common Stock — how do they compare? Corning Incorporated trades at $135.34 (market cap $127.95B), while Liquidia Corporation Common Stock trades at $34.9 (market cap $2.40B). The key difference: Corning Incorporated is far larger — about 53.3× Liquidia Corporation Common Stock's market cap, and Corning Incorporated pays a 0.75% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corning Incorporated for 36 Days and Liquidia Corporation Common Stock for 0 Days on average.
| GLW | LQDA | |
|---|---|---|
Market Cap | $127.95B | $2.40B |
Volume | 7,325,250 | 2,857,547 |
Sector | Technology | Health |
52-Week High | $255.79 | $91.03 |
52-Week Low | $78.03 | $22.02 |
Typical Hold Time | 36 Days | 0 Days |
Enterprise Value | $134.83B | $2.30B |
Dividend Yield | 0.75% | — |
Signals from Pluang's Aura AI — not financial advice
Corning (GLW) trades at $140.91, down 4.31% today, amid a bearish technical outlook despite strong fundamentals. The stock shows robust earnings beats in recent quarters and recently secured a significant $3 billion fiber supply agreement with AT&T, positioning it well for AI-driven infrastructure demand. Analyst consensus remains bullish with a $171.25 price target, though technical indicators signal near-term weakness with support at $134.
GLW presents a compelling long-term investment opportunity driven by its leadership in optical communications and materials science, supported by strong revenue growth and improving profit margins. Key risks include ongoing patent litigation and market volatility, but institutional confidence remains high with 57% buy ratings and projected 2026 revenue growth to $17 billion.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →